Recent advances in the management of diabetic pregnant women.
Recent advances in perinatology, neonatalogy, and metabolism have substantially improved the prognosis for pregnancy in patients with overt diabetes. Perinatal mortality rates are now approaching those in the general population; morbidity is declining. Yet to be conquered is the markedly increased incidence of congenital anomalies. Nevertheless, in 1980, one can give the pregnant diabetic patient more assurance than ever before that the outcome of her pregnancy is likely to be favorable.
D001786:Blood Glucose / Q000032:analysis; D036861:Delivery, Obstetric; D003927:Diet, Diabetic; D004964:Estriol / Q000097:blood; D005260:Female; D005323:Fetal Monitoring; D005325:Fetal Organ Maturity; D006027:Glycosides / Q000032:analysis; D006441:Hemoglobin A / Q000031:analogs & derivatives / Q000032:analysis; D006801:Humans; D007003:Hypoglycemia / Q000628:therapy; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000209:etiology / Q000628:therapy; D007328:Insulin / Q000627:therapeutic use; D007743:Labor, Obstetric; D008168:Lung / Q000196:embryology; D010349:Patient Compliance; D011247:Pregnancy; D011254:Pregnancy in Diabetics / Q000628:therapy*; D011933:Reagent Kits, Diagnostic; D012127:Respiratory Distress Syndrome, Newborn / Q000209:etiology
D001786:Blood Glucose; D006027:Glycosides; D007328:Insulin; D011933:Reagent Kits, Diagnostic; D006441:Hemoglobin A; D004964:Estriol